TCT-681 SOLACE AU Study: Interim results at one year of the Edwards SAPIEN XT TM Transcatheter Heart Valve in intermediate risk patients with severe aortic stenosis in Australia

We report the clinical outcomes of intermediate-risk patients at one year from the SOLACE AU Registry who received the Edwards SAPIEN XT TM Transcatheter Heart Valve (THV). This is a single arm multi-centre study in 11 centres throughout Australia of select symptomatic patients with severe aortic